Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Let me suggest
20
Aug 11, 2010 10:09PM

Re: "Seems that in order to increase its revenues, the company in the nearest future will rely not only on growing royalty rates, but on litigation for the non purchasing of MMP licenses." http://www.hotstocked.com/article/2612/patriot-scientific-corporation-otc-ptsc-stock.html

Relying on royalty income from "litigation" for non purchasing of MMP licenses is not helpful in the near term. Litigation takes a long time, as we've seen over and over again. We need income without litigation, a lot of it, and soon.

3
Aug 12, 2010 12:27PM
Share
New Message
Please login to post a reply